Back to Search
Start Over
Deletion of a putative promoter-proximal Tnfsf11 regulatory region in mice does not alter bone mass or Tnfsf11 expression in vivo.
- Source :
-
PloS one [PLoS One] 2021 May 10; Vol. 16 (5), pp. e0250974. Date of Electronic Publication: 2021 May 10 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- The cytokine RANKL is essential for osteoclast formation during physiological and pathological bone resorption. RANKL also contributes to lymphocyte production, development of lymph nodes and mammary glands, as well as other biological activities. Transcriptional control of the Tnfsf11 gene, which encodes RANKL, is complex and involves distant regulatory regions. Nevertheless, cell culture studies suggest that an enhancer region near the transcription start site is involved in the control of Tnfsf11 expression by hormones such as 1,25-(OH)2 vitamin D3 and parathyroid hormone, as well as the sympathetic nervous system. To address the significance of this region in vivo, we deleted the sequence between -510 to -1413 bp, relative to Tnfsf11 exon 1, from mice using CRISPR-based gene editing. MicroCT analysis of the femur and fourth lumbar vertebra of enhancer knockout mice showed no differences in bone mass compared to wild type littermates at 5 weeks and 6 months of age, suggesting no changes in osteoclast formation. RNA extracted from the tibia, fifth lumbar vertebra, thymus, and spleen at 6 months of age also showed no reduction in Tnfsf11 mRNA abundance between these groups. However, maximal stimulation of Tnfsf11 mRNA abundance in cultured stromal cells by PTH was reduced approximately 40% by enhancer deletion, while stimulation by 1,25-(OH)2 vitamin D3 was unaffected. The abundance of B and T lymphocytes in the bone marrow did not differ between genotypes. These results demonstrate that the region between -510 and -1413 does not contribute to Tnfsf11 expression, osteoclast support, or lymphocyte production in mice under normal physiological conditions but may be involved in situations of elevated parathyroid hormone.<br />Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: CAO owns stock in Radius Health, Inc. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
- Subjects :
- Animals
CRISPR-Cas Systems
Cells, Cultured
Female
Lymphocytes physiology
Male
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Knockout
Models, Animal
Osteoclasts cytology
Parathyroid Hormone metabolism
Promoter Regions, Genetic
RANK Ligand metabolism
Regulatory Sequences, Nucleic Acid
Bone Density physiology
Osteoclasts physiology
RANK Ligand genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1932-6203
- Volume :
- 16
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- PloS one
- Publication Type :
- Academic Journal
- Accession number :
- 33970941
- Full Text :
- https://doi.org/10.1371/journal.pone.0250974